Cargando…

A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India

BACKGROUND: The unprecedented first wave of the COVID-19 pandemic severely impacted mental health services globally. However, the negative impact of such disruptions on people with substance use disorders (SUD) seeking treatment remains unclear. We aim to explore the behaviors adopted by these indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, Sidharth, Ghosh, Abhishek, Mishra, Shree, Swami, Mukesh Kumar, Prasad, Sambhu, Somani, Aditya, Basu, Aniruddha, Sharma, Kshitiz, Padhy, Susanta Kumar, Nebhinani, Naresh, Singh, Lokesh Kumar, Choudhury, Shinjini, Basu, Debasish, Gupta, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992763/
https://www.ncbi.nlm.nih.gov/pubmed/35400749
http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_557_21
_version_ 1784683795233898496
author Arya, Sidharth
Ghosh, Abhishek
Mishra, Shree
Swami, Mukesh Kumar
Prasad, Sambhu
Somani, Aditya
Basu, Aniruddha
Sharma, Kshitiz
Padhy, Susanta Kumar
Nebhinani, Naresh
Singh, Lokesh Kumar
Choudhury, Shinjini
Basu, Debasish
Gupta, Rajiv
author_facet Arya, Sidharth
Ghosh, Abhishek
Mishra, Shree
Swami, Mukesh Kumar
Prasad, Sambhu
Somani, Aditya
Basu, Aniruddha
Sharma, Kshitiz
Padhy, Susanta Kumar
Nebhinani, Naresh
Singh, Lokesh Kumar
Choudhury, Shinjini
Basu, Debasish
Gupta, Rajiv
author_sort Arya, Sidharth
collection PubMed
description BACKGROUND: The unprecedented first wave of the COVID-19 pandemic severely impacted mental health services globally. However, the negative impact of such disruptions on people with substance use disorders (SUD) seeking treatment remains unclear. We aim to explore the behaviors adopted by these individuals to overcome the service disruptions. MATERIALS AND METHODS: We explored the changes related to substance use behavior (quit attempts, withdrawal experienced, treatment-seeking, and risky behaviors), and behavioral changes in response to COVID-19 lockdown. A cross-sectional survey was conducted among 404 people with SUD seeking treatment from seven centers across India. They were assessed by a specially designed structured questionnaire during the first wave (June–September) of the pandemic. RESULTS: An overwhelming majority experienced withdrawal symptoms, with close to half making quit attempts and seeking treatment during the lockdown. Three-fourth of the sample reported difficulty in accessing treatment services and medications. Patients with opioid use were significantly more likely to think about quitting (χ(2) = 20.408, P = 0.000), make attempts (χ(2) = 12.436, P = 0.000), seek treatment (χ(2) = 7.536, P = 0.006), and self-medicate for withdrawal symptoms (χ(2) = 5.885, P = 0.015). In turn, those with alcohol use were more likely to use telepsychiatry services (χ(2) = 35.143, P = 0.000) and experience stigma by family members (χ(2) = 29.951, P = 0.000) and neighbors (χ(2) = 17.725, P = 0.000). Among COVID-19 safety precautions, majority practised wearing masks and social distancing but not others. CONCLUSION: COVID-19 lockdown led a significant proportion of substance users, especially opioid users, to make quit attempts and seek help. However, these could not be sustained due to difficulty in accessing treatment services. Further, significant proportion failed to adhere to COVID-19 safety precautions.
format Online
Article
Text
id pubmed-8992763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-89927632022-04-09 A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India Arya, Sidharth Ghosh, Abhishek Mishra, Shree Swami, Mukesh Kumar Prasad, Sambhu Somani, Aditya Basu, Aniruddha Sharma, Kshitiz Padhy, Susanta Kumar Nebhinani, Naresh Singh, Lokesh Kumar Choudhury, Shinjini Basu, Debasish Gupta, Rajiv Indian J Psychiatry Original Article BACKGROUND: The unprecedented first wave of the COVID-19 pandemic severely impacted mental health services globally. However, the negative impact of such disruptions on people with substance use disorders (SUD) seeking treatment remains unclear. We aim to explore the behaviors adopted by these individuals to overcome the service disruptions. MATERIALS AND METHODS: We explored the changes related to substance use behavior (quit attempts, withdrawal experienced, treatment-seeking, and risky behaviors), and behavioral changes in response to COVID-19 lockdown. A cross-sectional survey was conducted among 404 people with SUD seeking treatment from seven centers across India. They were assessed by a specially designed structured questionnaire during the first wave (June–September) of the pandemic. RESULTS: An overwhelming majority experienced withdrawal symptoms, with close to half making quit attempts and seeking treatment during the lockdown. Three-fourth of the sample reported difficulty in accessing treatment services and medications. Patients with opioid use were significantly more likely to think about quitting (χ(2) = 20.408, P = 0.000), make attempts (χ(2) = 12.436, P = 0.000), seek treatment (χ(2) = 7.536, P = 0.006), and self-medicate for withdrawal symptoms (χ(2) = 5.885, P = 0.015). In turn, those with alcohol use were more likely to use telepsychiatry services (χ(2) = 35.143, P = 0.000) and experience stigma by family members (χ(2) = 29.951, P = 0.000) and neighbors (χ(2) = 17.725, P = 0.000). Among COVID-19 safety precautions, majority practised wearing masks and social distancing but not others. CONCLUSION: COVID-19 lockdown led a significant proportion of substance users, especially opioid users, to make quit attempts and seek help. However, these could not be sustained due to difficulty in accessing treatment services. Further, significant proportion failed to adhere to COVID-19 safety precautions. Wolters Kluwer - Medknow 2022 2022-01-21 /pmc/articles/PMC8992763/ /pubmed/35400749 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_557_21 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Arya, Sidharth
Ghosh, Abhishek
Mishra, Shree
Swami, Mukesh Kumar
Prasad, Sambhu
Somani, Aditya
Basu, Aniruddha
Sharma, Kshitiz
Padhy, Susanta Kumar
Nebhinani, Naresh
Singh, Lokesh Kumar
Choudhury, Shinjini
Basu, Debasish
Gupta, Rajiv
A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India
title A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India
title_full A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India
title_fullStr A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India
title_full_unstemmed A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India
title_short A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India
title_sort multicentric survey among patients with substance use disorders during the covid-19 lockdown in india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992763/
https://www.ncbi.nlm.nih.gov/pubmed/35400749
http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_557_21
work_keys_str_mv AT aryasidharth amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT ghoshabhishek amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT mishrashree amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT swamimukeshkumar amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT prasadsambhu amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT somaniaditya amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT basuaniruddha amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT sharmakshitiz amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT padhysusantakumar amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT nebhinaninaresh amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT singhlokeshkumar amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT choudhuryshinjini amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT basudebasish amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT guptarajiv amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT aryasidharth multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT ghoshabhishek multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT mishrashree multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT swamimukeshkumar multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT prasadsambhu multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT somaniaditya multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT basuaniruddha multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT sharmakshitiz multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT padhysusantakumar multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT nebhinaninaresh multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT singhlokeshkumar multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT choudhuryshinjini multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT basudebasish multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia
AT guptarajiv multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia